This is Figure 2 from the article in Radiology: Acute encephalopathy. A 60 year-old-man without history of seizures presenting with convulsion. (A-B) Multifocal areas of FLAIR hyperintensity in the right cerebellum (arrows in A), left anterior cingular cortex and superior frontal gyrus (arrows in B). (C-D) Restricted diffusion in the left anterior cingulate cortex, superior frontal and middle temporal gyrus (arrows in D) and right cerebellum (arrows in E), consistent with cerebellar diaschisis. F) #COVID19

Four recent radiology studies, from New York, Italy, Iran and China, show how COVID-19 (SARS-CoV-2) impacts the brain of some infected patients. Accumulating evidence suggests that a subgroup of patients with severe COVID-19 might have a cytokine storm syndrome which could be a trigger for ischemic strokes. Other abnormalities have also been found in COVID-19 patient brain imaging studies.

 

 

Flattening the curve. Slowing the spread. I have yet to read — or hear — anyone say we are trying to stop the coronavirus virus. To beat it. The closest has been a news commentator saying that if everyone stopped in their tracks, six feet apart from everyone else, the spread of the virus would end immediately.

June 2, 2020 — Early diagnosis of cancer is one of the highest-priority problem for the healthcare system, because it is critical for overall treatment success and saving patients' lives. Diffusion-weighted magnetic resonance imaging (DWI) may be used to detect a malignancy in various tissues and organs. It has the advantage of providing insight into the diffusion of water molecules in body tissues without exposing patients to radiation.

June 2, 2020 — Lunit announced that its artificial intelligence (AI) solution for breast cancer, Lunit INSIGHT MMG, has been CE certified. The medical software was certified on May 26, making it now commercially available across the European Economic Area, including 27 member countries of the European Union, United Kingdom, as well as the European Free Trade Association.

June 1, 2020 — While acknowledging the challenges their specialty is facing, more than two-thirds of respondents to an American Society of Nuclear Cardiology (ASNC) member survey are confident nuclear cardiology volumes will return to pre-pandemic levels. 

June 1, 2020 — RaySearch Laboratories AB and Varian Medical Systems have entered into an interoperability agreement that will allow the RayCare oncology information system to connect to Varian TrueBeam linear accelerators.

June 1, 2020 — TAUVID, a radioactive diagnostic agent, has been approved by the FDA for positron emission tomography (PET) imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs) in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD). A neuropathological diagnosis of AD requires the demonstration of the presence of both b

June 1, 2020 — RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy (BgRT) for treating all stages of cancer, announced a clinical collaboration with Merck to evaluate the safety and efficacy of KEYTRUDA (pembrolizumab), Merck’s anti-PD-1 therapy, in combination with BgRT in multiple late-stage canc

May 29, 2020 — GE Healthcare announced U.S. FDA 510(k) clearance of AIR Recon DL. This pioneering technology, using a deep learning-based neural network, improves the patient experience through shorter scan times while also increasing diagnostic confidence with better image quality across all anatomies.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now